VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Clinical factors scoring system for CAR-T patient selection in R/R multiple myeloma

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, Cleveland Clinic, Cleveland, OH, discusses the challenges in access to commercial CAR-T therapies for patients with relapsed/refractory (R/R) multiple myeloma in the US, outlining a novel clinical factors scoring system to better allocate slots to patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter